DETAILED ACTION
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
The office acknowledges the receipt of applicants’ response to the restriction requirement dated 07/23/2026.
PNG
media_image1.png
298
632
media_image1.png
Greyscale
A search of the prior art did not show the elected species. As no claims where specifically drawn to applicants’ elected species in independent form, no claims have been indicated as allowable. Claims written in independent form which require all the limitations of the elected species along with any dependent claims which require all the limitations of the elected species would be allowable. Under MPEP 803.02, the search was expanded to find an examinable species.
Examinable Species
The examinable species is represented by BOUD-pg71 (page 71):
PNG
media_image2.png
218
386
media_image2.png
Greyscale
BOUD-pg71 reads on claims 1-7, 10-11, 13-14, 17-20. Claims 8-9, 12, 15-16 are withdrawn as not reading on the examinable species.
Claim Rejections - 35 USC § 102
The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale or otherwise available to the public before the effective filing date of the claimed invention.
Claim(s) 1-7, 10-11, 13-14, 17-20 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by BOUDREAULT (US 20200227659 A1).
Regarding Claims 1-7, 10-11, 13-14, BOUDREAULT teaches an iridium complex represented by BOUD-pg71 (page 71):
PNG
media_image2.png
218
386
media_image2.png
Greyscale
BOUD-pg71 reads on applicants’ Formula 1 wherein Ring A =aza-dibenzothiophene; RA = di-trifluoromethyl-propyl; Ring B = naphthene; RB = Hx = 2; y=1; c = 0; Z1 = N; (per claims 1-7).
LA =
PNG
media_image3.png
188
108
media_image3.png
Greyscale
, RA = di-trifluoromethyl-propyl, X(s) = C; Ring A =aza-dibenzothiophene; X5 = RA = di-trifluoromethyl-propyl (per claim 10)
A =
PNG
media_image4.png
210
188
media_image4.png
Greyscale
, RAA = di-trifluoromethyl-propyl; X(s) = C; X10 =RAA = di-trifluoromethyl-propyl; YA1 = S; RBB = t-butyl (per claim 11).
The complex reads on Ir (LA)2(LB) (per claim 13).
The complex reads on
PNG
media_image5.png
198
164
media_image5.png
Greyscale
K1 = direct bond; Y1-Y10 = C; Rb = t-butyl; RAA= di-trifluoromethyl-propyl (per claim 14).
Regarding Claims 17-20, OLED comprising a first organic layer that contains a compound as disclosed in the above compounds section of the present disclosure. In some embodiments, the OLED comprises: an anode; a cathode; and an organic layer disposed between the anode and the cathode, wherein the organic layer comprises a compound comprising a ligand (paragraph 110) (per claim 17).
The organic layer may also have a host comprising at least one chemical group selected from the group consisting of triphenylene, carbazole, dibenzothiophene, dibenzofuran, dibenzoselenophene, azatriphenylene, azacarbazole, aza-dibenzothiophene, aza-dibenzofuran, and aza-dibenzoselenophene. A specific example can be represented by (paragraph 120):
PNG
media_image6.png
220
348
media_image6.png
Greyscale
(per claims 18-19).
The OLED can be incorporated into one or more of a consumer product, an electronic component module, and a lighting panel (paragraph 118) (per claim 20).
Conclusion
Any inquiry concerning this communication or earlier communications from the examiner should be directed to GREGORY D CLARK whose telephone number is (571)270-7087. The examiner can normally be reached on 8AM-4PM M-F.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer Chriss can be reached on 571-272-7783. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/GREGORY D CLARK/Primary Examiner, Art Unit 1786
Prosecution Insights